rs397516387
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP2PP3_ModeratePP5
The NM_001018005.2(TPM1):c.725C>T(p.Ala242Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,882 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A242A) has been classified as Benign.
Frequency
Consequence
NM_001018005.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPM1 | NM_001018005.2 | c.725C>T | p.Ala242Val | missense_variant | 8/10 | ENST00000403994.9 | NP_001018005.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPM1 | ENST00000403994.9 | c.725C>T | p.Ala242Val | missense_variant | 8/10 | 1 | NM_001018005.2 | ENSP00000385107 | A1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251462Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135902
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461882Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727240
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Primary dilated cardiomyopathy Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 12, 2023 | The p.Ala242Val variant in TPM1 has been reported in at least 5 individuals with dilated cardiomyopathy (DCM; Walsh 2017 PMID: 27532257, Van Lint 2019 PMID: 30847666, Khan 2022 PMID: 34935411, LMM data), in at least 2 individuals with left ventricular non-compaction (LVNC; Tian 2015 PMID: 24691700, Li 2018 PMID: 30371277, Miszalski-Jamka 2018 PMID: 28798025) and in 1 individual with left ventricular dysfunction and unspecified cardiomyopathy in whom the variant occurred de novo (Invitae Personal Communication 2023). In one of individuals with DCM, this variant was also identified in an affected relative with DCM (LMM data). This variant has also been reported by other clinical laboratories in ClinVar (Variation ID 43437) and was absent from large population studies. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PS4_Moderate, PM2_Supporting, PS2_Supporting, PP3. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Clinical Center for Gene Diagnosis and Therapy, Department of Cardiovascular Surgery, The Second Xiangya Hospital of Central South University | Jun 01, 2023 | - - |
Dilated cardiomyopathy 1Y Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | New York Genome Center | Jul 17, 2020 | The heterozygous c.725C>T (p.Ala242Val) variant identified in the TPM1 gene substitutes a well conserved Alanine for Valine at amino acid 242/285 (exon 8/10). This variant is absent from gnomAD(v3.0) suggesting it is not a common benign variant in the populations represented in that database. In silico algorithms predict this variant to be Deleterious (Provean; score:-3.3) and Damaging (SIFT; score:0.00) to the function of the canonical transcript. This variant is reported in ClinVar as a Variant of Uncertain Significance (VarID:43437), and has been identified in several individuals in the literature with left ventricular non-compaction [PMID:24691700; PMID:30371277; PMID:28798025] and dilated cardiomyopathy [PMID:27532257; PMID:24503780; PMID:30847666]. Given its absence in population databases, in silico prediction of damaging effect to protein function, and its observation in several affected individuals in the literature, the heterozygous c.725C>T (p.Ala242Val) variant identified in the TPM1 gene is reported as Likely Pathogenic. - |
Hypertrophic cardiomyopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 19, 2023 | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 242 of the TPM1 protein (p.Ala242Val). This variant is present in population databases (rs397516387, gnomAD 0.0009%). This missense change has been observed in individual(s) with dilated cardiomyopathy and/or left ventricular noncompaction (PMID: 24691700, 27532257, 30847666, 34935411; Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 43437). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 25, 2023 | The p.A242V variant (also known as c.725C>T), located in coding exon 8 of the TPM1 gene, results from a C to T substitution at nucleotide position 725. The alanine at codon 242 is replaced by valine, an amino acid with similar properties. This variant has been detected in several unrelated individuals with dilated cardiomyopathy (DCM) and/or left ventricular noncompaction cardiomyopathy (LVNC), including a reported de novo occurrence and reported segregation with disease in a family (Pugh TJ et al. Genet Med, 2014 Aug;16:601-8; Tian T et al. Heart Vessels, 2015 Mar;30:258-64; Miszalski-Jamka K et al. Circ Cardiovasc Genet, 2017 Aug;10; van Lint FHM et al. Neth Heart J, 2019 Jun;27:304-309; Khan RS et al. J Am Heart Assoc, 2022 Jan;11:e022854; van der Meulen MH et al. Circ Genom Precis Med, 2022 Oct;15:e002981; Meshkov AN et al. Front Cardiovasc Med, 2023 May;10:1205787). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This missense alteration is located in a region that has a low rate of benign missense variation (Lek M et al. Nature. 2016 Aug 18;536(7616):285-91; DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources. Firth H.V. et al. 2009. Am.J.Hum.Genet. 84, 524-533 (DOI: dx.doi.org/10/1016/j.ajhg.2009.03.010)). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at